Skip to Main Content

Paper Details

Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.
Cancer Med
8
2023
CDK4, CDK4/6, Cyclin-dependent kinase 4, EWS, Ewing sarcoma, IGF-1, IGF-1R, IGF-1R monoclonal antibody, Patients, ctDNA, ganitumab, neutropenia, palbociclib, patient, patients, sarcoma, thrombocytopenia, white blood cell
Author NameAffiliation
Kimberly StegmaierDana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School
Kimberly StegmaierDana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School
Brian D CromptonDana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School
Steven G DuBoisDana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School
  • 1 - 4

Datasets

Release 1.2